Bim BH3 Domain Antibody Blocking Peptide

Bim BH3 Domain Antibody Blocking Peptide

€363.00
In stock
SKU
AC-BP1308a
Catalog Number: AC-BP1308a
Size: 500 µg
Datasheet
Request Information
Background:
Bim belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. Bim contains a Bcl-2 homology domain 3 (BH3). It has been shown to interact with other members of the BCL-2 protein family, including BCL2, BCL2L1/BCL-X(L), and MCL1, and to act as an apoptotic activator. The expression of this gene can be induced by nerve growth factor (NGF), as well as by the forkhead transcription factor FKHR-L1, which suggests a role of this gene in neuronal and lymphocyte apoptosis. Transgenic studies of the mouse counterpart suggested that this gene functions as an essential initiator of apoptosis in thymocyte-negative selection.

Other Names:
Bcl-2-like protein 11, Bcl2-L-11, Bcl2-interacting mediator of cell death, BCL2L11, BIM

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1308a was selected from the region of human Bim BH3 Domain. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: BCL2L11

Gene ID: 10018
Primary Accession: O43521
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:Bim BH3 Domain Antibody Blocking Peptide